Wilmington, NC, United States of America

Dean G Shirazi


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dean G Shirazi: Innovator in Pharmaceutical Compositions

Introduction

Dean G Shirazi is a notable inventor based in Wilmington, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions involving estrogenic compounds. His work has implications for treating various medical conditions in mammals.

Latest Patents

Dean G Shirazi holds a patent for "Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds." This patent describes a composition of matter that includes a mixture of active estrogenic compounds in chemically pure form. The mixture consists of various conjugated estrogens, including salts of conjugated estrone, equilin, and estradiol, among others. The patent also outlines methods for analyzing these mixtures and drug products that utilize the composition for therapeutic purposes.

Career Highlights

Shirazi's career is marked by his innovative approach to pharmaceutical development. His patent reflects a deep understanding of the complexities involved in creating effective drug formulations. He has dedicated his efforts to improving the quality and efficacy of estrogenic compounds, which are crucial for various treatments.

Collaborations

Throughout his career, Dean G Shirazi has collaborated with esteemed colleagues, including Edward N Hill and Thomas W Leonard. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Dean G Shirazi's work in pharmaceutical compositions showcases his commitment to innovation in the field. His contributions, particularly in the area of estrogenic compounds, have the potential to impact medical treatments significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…